Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy.

Chen, June; Dinh, Tim; Woodward, David F; Holland, Michael; Yuan, Yang-Dar; Lin, Tsung-Hua; Wheeler, Larry A

Chen, June; Dinh, Tim; Woodward, David F; Holland, Michael; Yuan, Yang-Dar; Lin, Tsung-Hua; Wheeler, Larry A.

Affiliation

Chen J; Department of Biological Sciences (RD3), Allergan Inc., 2525 Dupont Drive, Irvine, CA 92612, USA. chen_june@allergan.com

Cardiovasc Drug Rev ; 23(3): 231-46, 2005.

Article in En | MEDLINE | ID: mdl-16252016

Subject(s)

Hyperemia/chemically induced; Lipids/therapeutic use; Administration, Topical; Amides; Animals; Bimatoprost; Clinical Trials as Topic; Cloprostenol/analogs & derivatives; Conjunctiva/drug effects; Conjunctiva/ultrastructure; Drug Evaluation, Preclinical/methods; Enzyme Inhibitors/administration & dosage; Enzyme Inhibitors/therapeutic use; Humans; Hyperemia/prevention & control; Lipids/administration & dosage; Lipids/adverse effects; NG-Nitroarginine Methyl Ester/administration & dosage; NG-Nitroarginine Methyl Ester/therapeutic use; Nitric Oxide Synthase/antagonists & inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Hyperemia / Lipids Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cardiovasc Drug Rev Year: 2005 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links